Senior-Loken syndrome
ORPHA:3156DiseaseAutosomal recessiveAdolescent, Adult, Childhood, Infancy
Ассоциированные гены10
| Ген | Полное название | Тип связи | Тип гена | OMIM |
|---|---|---|---|---|
| CEP290 | centrosomal protein 290 | Disease-causing germline mutation(s) in | gene with protein product | 610142 |
| INVS | inversin | Disease-causing germline mutation(s) in | gene with protein product | 243305 |
| IQCB1 | IQ motif containing B1 | Disease-causing germline mutation(s) in | gene with protein product | 609237 |
| NPHP1 | nephrocystin 1 | Disease-causing germline mutation(s) in | gene with protein product | 607100 |
| NPHP3 | nephrocystin 3 | Disease-causing germline mutation(s) in | gene with protein product | 608002 |
| NPHP4 | nephrocystin 4 | Disease-causing germline mutation(s) in | gene with protein product | 607215 |
| SDCCAG8 | SHH signaling and ciliogenesis regulator SDCCAG8 | Disease-causing germline mutation(s) in | gene with protein product | 613524 |
| WDR19 | WD repeat domain 19 | Disease-causing germline mutation(s) in | gene with protein product | 608151 |
| CEP164 | centrosomal protein 164 | Disease-causing germline mutation(s) in | gene with protein product | 614848 |
| TRAF3IP1 | TRAF3 interacting protein 1 | Disease-causing germline mutation(s) (loss of function) in | gene with protein product | 607380 |
Фенотипы (HPO)16
Очень частый (80–99%)8
HP:0000505Visual impairment
HP:0000556Retinal dystrophy
HP:0000822Hypertension
HP:0001263Global developmental delay
HP:0003774Stage 5 chronic kidney disease
HP:0004322Short stature
HP:0007703Abnormality of retinal pigmentation
HP:0012622Chronic kidney disease
Частый (30–79%)3
HP:0000090Nephronophthisis
HP:0000529Progressive visual loss
HP:0008209Premature ovarian insufficiency
Периодический (5–29%)5
HP:0000518Cataract
HP:0001251Ataxia
HP:0002612Congenital hepatic fibrosis
HP:0004348Abnormality of bone mineral density
HP:0010579Cone-shaped epiphysis
Эпидемиология1
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | 1-9 / 1 000 000 | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)